JP2003221386A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003221386A5 JP2003221386A5 JP2002341477A JP2002341477A JP2003221386A5 JP 2003221386 A5 JP2003221386 A5 JP 2003221386A5 JP 2002341477 A JP2002341477 A JP 2002341477A JP 2002341477 A JP2002341477 A JP 2002341477A JP 2003221386 A5 JP2003221386 A5 JP 2003221386A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- optionally substituted
- substituted
- atom
- single bond
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 125000003118 aryl group Chemical group 0.000 claims 22
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 18
- 229910052757 nitrogen Inorganic materials 0.000 claims 15
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 15
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 12
- 125000004430 oxygen atom Chemical group O* 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 11
- 229910052717 sulfur Inorganic materials 0.000 claims 10
- 125000004434 sulfur atom Chemical group 0.000 claims 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 9
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims 7
- 125000005843 halogen group Chemical group 0.000 claims 7
- 125000000623 heterocyclic group Chemical group 0.000 claims 7
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 3
- 125000005530 alkylenedioxy group Chemical group 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 2
- 125000001931 aliphatic group Chemical group 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 239000000651 prodrug Substances 0.000 claims 2
- 229940002612 prodrug Drugs 0.000 claims 2
- 229940121649 protein inhibitor Drugs 0.000 claims 2
- 239000012268 protein inhibitor Substances 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 125000002723 alicyclic group Chemical group 0.000 claims 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 230000003449 preventive effect Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002341477A JP2003221386A (ja) | 2001-11-26 | 2002-11-25 | 二環性誘導体、その製造法およびその用途 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001359753 | 2001-11-26 | ||
| JP2001-359753 | 2001-11-26 | ||
| JP2002341477A JP2003221386A (ja) | 2001-11-26 | 2002-11-25 | 二環性誘導体、その製造法およびその用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003221386A JP2003221386A (ja) | 2003-08-05 |
| JP2003221386A5 true JP2003221386A5 (cg-RX-API-DMAC7.html) | 2005-09-08 |
Family
ID=27759288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002341477A Ceased JP2003221386A (ja) | 2001-11-26 | 2002-11-25 | 二環性誘導体、その製造法およびその用途 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2003221386A (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060087386A (ko) * | 2005-01-28 | 2006-08-02 | 주식회사 대웅제약 | 신규 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물 |
| CR9465A (es) * | 2005-03-25 | 2008-06-19 | Surface Logix Inc | Compuestos mejorados farmacocineticamente |
| SI1945632T1 (sl) | 2005-11-08 | 2014-03-31 | Vertex Pharmaceuticals Incorporated | Heterocikliäśni modulatorji za prenaĺ alce z atp-vezavno kaseto |
| EP2164840A2 (en) | 2007-05-09 | 2010-03-24 | Vertex Pharmaceuticals Incorporated | Modulators of cftr |
| PT2225230T (pt) | 2007-12-07 | 2016-12-07 | Vertex Pharma | Formas sólidas de ácido 3-(6(1-(2,2-difluorobenzo[d][1,3] dioxol-5-il) ciclopropanocarboxamido)-3-metilpiridin-2-il) benzoico |
| PL2639223T3 (pl) | 2007-12-07 | 2017-09-29 | Vertex Pharmaceuticals Incorporated | Sposób wytwarzania kwasów cykloalkilokarboksyamido-pirydyno-benzoesowych |
| NZ620944A (en) | 2008-02-28 | 2015-02-27 | Vertex Pharma | Heteroaryl derivatives as cftr modulators |
| WO2010016490A1 (ja) | 2008-08-05 | 2010-02-11 | 第一三共株式会社 | イミダゾピリジン－２－オン誘導体 |
| HRP20211752T1 (hr) | 2010-04-07 | 2022-02-18 | Vertex Pharmaceuticals Incorporated | Farmaceutski pripravci 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzojeve kiseline i njihova primjena |
| MX2013008083A (es) * | 2011-01-21 | 2013-09-13 | Boehringer Ingelheim Int | Dihidrofuranos fusionados como moduladores de gpr119 para el tratamiento de diabetes, obesidad y trastornos relacionados. |
| BR122021002201A8 (pt) * | 2011-02-25 | 2023-04-11 | Merck Sharp & Dohme | Composto, composição, uso de um composto, e, método de tratamento de um distúrbio, condição ou doença |
| JP6327431B2 (ja) * | 2012-10-26 | 2018-05-23 | 国立大学法人三重大学 | がん細胞阻害薬、がん幹細胞検出用プローブ |
| US9246108B2 (en) * | 2012-12-28 | 2016-01-26 | Dow Global Technologies Llc | Quinoline-benzoxazole derived compounds for electronic films and devices |
| KR102280372B1 (ko) | 2013-11-12 | 2021-07-22 | 버텍스 파마슈티칼스 인코포레이티드 | Cftr 매개된 질환 치료용 약제학적 조성물의 제조 방법 |
| GB201321739D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
| DK3221692T3 (da) | 2014-11-18 | 2021-08-23 | Vertex Pharma | Fremgangsmåde til udførsel af tests med høj kapacitet ved hjælp af højtryksvæskekromatografi |
| GB201506660D0 (en) * | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
| CN116903554A (zh) * | 2023-09-13 | 2023-10-20 | 北京科翔中升医药科技有限公司 | Vista和pd-1/pd-l1双靶点小分子抑制剂及其制备方法和用途 |
-
2002
- 2002-11-25 JP JP2002341477A patent/JP2003221386A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003221386A5 (cg-RX-API-DMAC7.html) | ||
| JP2008510828A5 (cg-RX-API-DMAC7.html) | ||
| JP2005523310A5 (cg-RX-API-DMAC7.html) | ||
| WO2003080580A3 (en) | Quinoline derivatives and their use as 5-ht6 ligands | |
| WO2004052893A3 (en) | Substituted dihydropyrano indole-3,4-dione derivatives and 3-oxoacetic acid substituted 2-hydroxymethylindole derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
| RU2002123350A (ru) | Дипептиднитрильные ингибиторы катепсина К | |
| RU2005135162A (ru) | Арилзамещенные пиразоламиды в качестве ингибиторов киназ | |
| EE200200148A (et) | Kinasoliini derivaadid, nende valmistamise meetodning kasutamine | |
| EP1953154A4 (en) | CINNAMIDE COMPOUNDS OF MORPHOLINE TYPE | |
| MXPA03010445A (es) | Derivados de 4(fenil-piperazinil-metil) benzamida y su uso para tratamiento del dolor, ansiedad o trastornos gastrointestinales. | |
| JP2010504930A5 (cg-RX-API-DMAC7.html) | ||
| EA200501730A1 (ru) | Производные n-пирролидин-3-ил-амида в качестве ингибиторов обратного захвата серотонина и норадреналина | |
| JP2007500734A5 (cg-RX-API-DMAC7.html) | ||
| SE0103313D0 (sv) | Novel compounds | |
| ATE429429T1 (de) | Pharmazeutisches verfahren und damit hergestellte verbindungen | |
| JP2003503505A5 (cg-RX-API-DMAC7.html) | ||
| JP2004523478A5 (cg-RX-API-DMAC7.html) | ||
| EA200701780A1 (ru) | Противоопухолевое средство | |
| NO20063330L (no) | Amidderivater med en syklopropylaminokarbonylsubstituent som er nyttige som cytokininhibitorer | |
| PL356797A1 (en) | Novel compounds | |
| CA2486836A1 (en) | Multi-substituted imidazolines and method of use thereof | |
| PE20061155A1 (es) | Derivados de indolinona como agentes para el tratamiento o la prevencion de enfermedades fibroticas | |
| RU96101173A (ru) | Производные пиридазинонов | |
| CA2409842A1 (en) | 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists | |
| EP1491533A3 (en) | Quinoline-and naphthalenecarboxamides, pharmaceutical compositions thereof and their use as calpain inhibitors |